Deliver smarter, data-driven home health care with our new integration
A new integration is available that will make it easier home health providers to deliver high quality care. MatrixCare now seamlessly integrates with Medalogix, a leader in machine learning and AI-powered clinical decision support. This integration brings Medalogix’s Pulse platform directly to MatrixCare home health customers, unlocking advanced predictive analytics and actionable insights to improve patient care outcomes.
Why it matters
Home-based care providers face ongoing challenges, including evolving reimbursement models, staffing shortages and rising regulatory pressures. The integration of MatrixCare and Medalogix can help providers overcome these obstacles by empowering clinicians with tools to make smarter, more informed decisions.
This integration provides access to real-time insights throughout the patient care journey—from referral to discharge. The platform uses predictive analytics to guide care teams on appropriate visit utilization, care continuation, and proactive care planning, all tailored to individual patient risks and needs.
What is Medalogix Pulse?
Medalogix Pulse is a comprehensive clinical decision support suite designed to optimize care delivery in the home health setting. Its key component, Pulse Episodes, uses advanced data science to analyze clinical data and provide visit-by-visit risk assessments. This helps care teams:
- Optimize care planning: Proactively adjust care when patient risk increases to help prevent unplanned hospitalizations
- Align visits to patient needs: Improve care continuity by recommending risk-based recertification and discharge decisions
- Support value-based care goals: Ensure utilization aligns with patient conditions to meet Home Health Value-Based Purchasing (HHVBP) measures
- Enhance patient outcomes: Reduce unwanted hospital transfers by an average of 8.2% and improve visit alignment by 15.6%*
Benefits for providers and patients
Providers using Medalogix Pulse through MatrixCare can make informed care decisions based on cutting-edge machine learning. This helps care teams make sure patients receive the right number of visits, reducing the risk of inadequate care and unplanned hospitalizations.
“Partnering with Medalogix will give our clients the clinical insights they need to offset industry headwinds, so they can provide better, more informed care.”
Tim Smokoff, general manager of Home Health and Hospice at MatrixCare
Elliott Wood, president and CEO of Medalogix, shared his enthusiasm for the collaboration. “We are thrilled about this partnership and the opportunity to make Medalogix Pulse available to MatrixCare customers. Our mission is to ensure clinicians have the insights they need to make informed decisions and improve care delivery for patients at home.”
*Medalogix customer averages from January to May 2024. Results may vary.
See how this advanced technology could impact your organization.
MatrixCare
MatrixCare provides an extensive range of software solutions and services purpose-built for out-of-hospital care settings. As the multiyear winner of the Best in KLAS award for Long-Term Care Software and Home Health and Hospice EMR, MatrixCare is trusted by thousands of facility-based and home-based care organizations to improve provider efficiencies and promote a better quality of life for the people they serve. As an industry leader in interoperability, MatrixCare helps providers connect and collaborate across the care continuum to optimize outcomes and successfully manage risk in out-of-hospital care delivery.
MatrixCare is a wholly-owned subsidiary of ResMed (NYSE: RMD, ASX: RMD). To learn more, visit matrixcare.com and follow @MatrixCare on X
See MatrixCare in action
Start by having a call with one of our experts to see our platform in action.
MatrixCare offers industry-leading software solutions. Thousands of facility-based and home-based care organizations trust us to help them improve efficiency and provide exceptional care.
© 2025 MatrixCare is a registered trademark of MatrixCare. All rights reserved.